Nutex Health, Inc. (NUTX)
NASDAQ: NUTX · IEX Real-Time Price · USD
6.82
+0.10 (1.41%)
At close: Jul 19, 2024, 4:30 PM
7.03
+0.21 (3.15%)
Pre-market: Jul 22, 2024, 4:18 AM EDT
Nutex Health Revenue
Nutex Health had revenue of $258.77M in the twelve months ending March 31, 2024, with 31.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $67.45M with 19.75% year-over-year growth. In the year 2023, Nutex Health had annual revenue of $247.65M with 12.93% growth.
Revenue (ttm)
$258.77M
Revenue Growth
+31.69%
P/S Ratio
0.13
Revenue / Employee
$323,463
Employees
800
Market Cap
33.88M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 247.65M | 28.35M | 12.93% |
Dec 31, 2022 | 219.29M | -112.24M | -33.85% |
Dec 31, 2021 | 331.53M | 57.50M | 20.98% |
Dec 31, 2020 | 274.03M | 272.66M | 19,954.54% |
Dec 31, 2019 | 1.37M | -577.00 | -0.04% |
Dec 31, 2018 | 1.37M | 1.34M | 5,800.87% |
Dec 31, 2017 | 23.17K | - | - |
Dec 31, 2016 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Exagen | 55.73M |
Retractable Technologies | 40.20M |
iCAD, Inc. | 19.63M |
ReWalk Robotics | 17.91M |
Cyclo Therapeutics | 1.13M |
Orgenesis | 529.00K |
NUTX News
- 6 days ago - Nutex Health Hospitals Prove Patient Satisfaction with Nine Awards and Honors Earned in Q2 - PRNewsWire
- 24 days ago - NUTEX HEALTH ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT - PRNewsWire
- 4 weeks ago - NUTEX HEALTH ANNOUNCES THAT IT HAS OBTAINED APPROVAL FROM ITS SHAREHOLDERS TO EFFECT A REVERSE STOCK SPLIT - PRNewsWire
- 2 months ago - NUTEX HEALTH ANNOUNCES NASDAQ DELISTING NOTIFICATION AND STAY PENDING ONGOING APPEAL. NO IMMEDIATE EFFECT ON THE LISTING OR TRADING OF THE COMMON STOCK. - PRNewsWire
- 2 months ago - NUTEX HEALTH REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS - PRNewsWire
- 2 months ago - NUTEX HEALTH SCHEDULES 2024 FIRST QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL - PRNewsWire
- 2 months ago - NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2024 ANNUAL MEETING - PRNewsWire
- 3 months ago - NUTEX HEALTH HOSTS SECOND ANNUAL INTERNAL LEADERSHIP CONFERENCE - PRNewsWire